MedPath

Radboud University Medical Center

Radboud University Medical Center logo
🇳🇱Netherlands
Ownership
Private
Established
1951-01-01
Employees
-
Market Cap
-
Website
http://www.radboudumc.nl

Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients

Completed
Conditions
Bacterial Infections
First Posted Date
2018-11-13
Last Posted Date
2019-11-21
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
40
Registration Number
NCT03738683
Locations
🇳🇱

University Medical Centre Utrecht, Utrecht, Netherlands

🇳🇱

Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

The Effect Lactate Administration on Cerebral Blood Flow During Hypoglycemia

Not Applicable
Conditions
Type1diabetes
Hypoglycemia Unawareness
Interventions
First Posted Date
2018-11-05
Last Posted Date
2018-11-05
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
10
Registration Number
NCT03730909
Locations
🇳🇱

Radoud university medical center, Nijmegen, Netherlands

Effects of Self-administration of Medication During Hospitalization on Medication Safety, Adherence, and Patient Satisfaction in Dutch Hospitals

Not Applicable
Terminated
Conditions
Patient Safety
Medication Safety
Patient Empowerment
Interventions
Behavioral: Self-administration of medication (SAM)
First Posted Date
2018-11-02
Last Posted Date
2020-09-14
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
193
Registration Number
NCT03728855
Locations
🇳🇱

Sint Maartenskliniek, Ubbergen, Gelderland, Netherlands

🇳🇱

Radboudumc, Nijmegen, Gelderland, Netherlands

🇳🇱

Catharina Ziekenhuis, Eindhoven, Noord-Brabant, Netherlands

and more 5 locations

Cabozantinib in Advanced Salivary Gland Cancer Patients

Phase 2
Terminated
Conditions
Salivary Gland Cancer
Interventions
First Posted Date
2018-11-02
Last Posted Date
2021-03-12
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
25
Registration Number
NCT03729297
Locations
🇳🇱

Radboudumc, Nijmegen, Gelderland, Netherlands

Inspiratory Muscle Training in Nemaline Myopathy

Not Applicable
Completed
Conditions
Inspiratory Muscle Training
Nemaline Myopathy
Interventions
Device: Threshold IMT, Philips Respironics, Murrysville, PA, USA
First Posted Date
2018-11-02
Last Posted Date
2024-12-05
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
42
Registration Number
NCT03728803
Locations
🇳🇱

Radboud university medical center, Nijmegen, Netherlands

Bilateral TMS vs. Unilateral TMS

Not Applicable
Conditions
Orofacial Pain
Neuropathic Pain
Trigeminal Neuropathy
Interventions
Device: Transcranial magnetic stimulation
First Posted Date
2018-10-18
Last Posted Date
2018-10-18
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
12
Registration Number
NCT03710967
Locations
🇳🇱

Radboud University, Nijmegen, Gelderland, Netherlands

Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin

Phase 1
Conditions
Gastrointestinal Cancer
Colorectal Cancer
Neoplasms
Peritoneal Carcinomatosis
Carcinoma
Interventions
Drug: Indium-111-DOTA-Labetuzumab-IRDye800CW injection
Radiation: SPECT/CT scan
Procedure: CRS extended with dual-modality imaging
First Posted Date
2018-10-09
Last Posted Date
2019-09-13
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
29
Registration Number
NCT03699332
Locations
🇳🇱

Radboudumc, Nijmegen, Netherlands

PreColo Practice Variation

Terminated
Conditions
Postoperative Complications
Colon Cancer
Aging
First Posted Date
2018-09-24
Last Posted Date
2019-09-13
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
20
Registration Number
NCT03682133
Locations
🇳🇱

Gelre ziekenhuizen, Apeldoorn, Gelderland, Netherlands

🇳🇱

Radboudumc, Nijmegen, Gelderland, Netherlands

Dose Individualization of Pemetrexed - IMPROVE-I

Phase 4
Completed
Conditions
Non Small Cell Lung Cancer
Mesothelioma
Interventions
First Posted Date
2018-09-04
Last Posted Date
2024-12-17
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
6
Registration Number
NCT03656549
Locations
🇳🇱

Catharina hospital, Eindhoven, Netherlands

🇳🇱

Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands

🇳🇱

Antoni van Leeuwenhoek, Amsterdam, Netherlands

and more 3 locations

Dose Individualization of Pemetrexed - IMPROVE-II

Phase 4
Terminated
Conditions
Non Small Cell Lung Cancer
Mesothelioma
Interventions
First Posted Date
2018-08-31
Last Posted Date
2022-05-13
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
81
Registration Number
NCT03655821
Locations
🇳🇱

Maastricht University Medical centre, Maastricht, Netherlands

🇳🇱

Radboud university medical centre, Nijmegen, Netherlands

🇳🇱

Erasmus University Medical Centre, Rotterdam, Netherlands

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath